Predictive Oncology Inc (POAI)
0.915
0.00 (0.00%)
USD |
NASDAQ |
Sep 06, 16:00
0.9024
-0.01
(-1.38%)
After-Hours: 20:00
Predictive Oncology Revenue (TTM): 1.748M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.748M |
| March 31, 2024 | 1.960M |
| December 31, 2023 | 1.780M |
| September 30, 2023 | 1.808M |
| June 30, 2023 | 1.549M |
| March 31, 2023 | 1.431M |
| December 31, 2022 | 1.506M |
| September 30, 2022 | 1.618M |
| June 30, 2022 | 1.476M |
| March 31, 2022 | 1.455M |
| December 31, 2021 | 1.421M |
| September 30, 2021 | 1.238M |
| June 30, 2021 | 1.405M |
| March 31, 2021 | 1.238M |
| December 31, 2020 | 1.252M |
| September 30, 2020 | 1.306M |
| June 30, 2020 | 1.348M |
| March 31, 2020 | 1.451M |
| December 31, 2019 | 1.412M |
| September 30, 2019 | 1.376M |
| June 30, 2019 | 1.183M |
| March 31, 2019 | 1.255M |
| December 31, 2018 | 1.412M |
| September 30, 2018 | 1.320M |
| June 30, 2018 | 1.143M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.8913M |
| December 31, 2017 | 0.6548M |
| September 30, 2017 | 0.5741M |
| June 30, 2017 | 0.5562M |
| March 31, 2017 | 0.5348M |
| December 31, 2016 | 0.4565M |
| September 30, 2016 | 0.5002M |
| June 30, 2016 | 0.4514M |
| March 31, 2016 | 0.60M |
| December 31, 2015 | 0.6544M |
| September 30, 2015 | 0.6369M |
| June 30, 2015 | 0.9483M |
| March 31, 2015 | 1.033M |
| December 31, 2014 | 0.9516M |
| September 30, 2014 | 0.8675M |
| June 30, 2014 | 0.5781M |
| March 31, 2014 | 0.4106M |
| December 31, 2013 | 0.4681M |
| September 30, 2013 | 0.476M |
| June 30, 2013 | 0.4198M |
| March 31, 2013 | 0.2939M |
| December 31, 2012 | 0.1888M |
| September 30, 2012 | 0.1732M |
| June 30, 2012 | 0.1419M |
| March 31, 2012 | 0.1193M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.238M
Minimum
Mar 2021
1.960M
Maximum
Mar 2024
1.489M
Average
1.441M
Median
Revenue (TTM) Benchmarks
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 38.25M |
| InfuSystems Holdings Inc | 129.37M |
| Xtant Medical Holdings Inc | 110.94M |
| Catheter Precision Inc | 0.436M |